Gastrointestinal dysfunction in idiopathic Parkinson's disease;Gastrointestinale Störungen beim idiopathischen Parkinson-Syndrom

Nervenarzt

Volumn 83, Issue 10, 2012, Pages 1282-1291

  Del Tredici, K ^a   Jost, W H ^b  

^a UNIVERSITY OF ULM   (Germany)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

Autonomic nervous system; Enteric nervous system; Gastrointestinal disorders; Idiopathic Parkinson syndrome; Lewy pathology

Indexed keywords

ARTICLE; COLON; DIGESTIVE SYSTEM FUNCTION DISORDER; ESOPHAGUS; IDIOPATHIC DISEASE; MOTONEURON NUCLEUS; PARKINSON DISEASE; VAGUS NERVE;

GASTROINTESTINAL DISEASES; HUMANS; PARKINSON DISEASE;

EID: 84867982372     PISSN: 00282804     EISSN: 14330407     Source Type: Journal    
DOI: 10.1007/s00115-012-3575-9     Document Type: Article

References (115)

1. Braak H, Rüb U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517-536
2. Bloch A, Probst A, Bissig H et al (2006) a-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 12:284-295
3. Braak H, Vos RA de, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 396:67-72
4. Braak H, Sastre M, Bohl JRE et al (2007) Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 113:421-429
5. O'Sullivan SS, Williams DR, Gallagher DW et al (2008) Non-motor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Mov Disord 23:101-106
6. Gallagher DA, Lees AJ, Schrag A (2010) What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord 25:2493-2500
7. Stern MB, Siderowf AD (2010) Parkinson's at risk syndrome: can Parkinson's disease be predicted? Mov Disord 25(Suppl 1):89-93
8. Chaudhuri KR (2011) The debate of motor versus non-motor aspects of Parkinson's disease: time for marriage. Basal Ganglia 1:47-48
9. Lang AE (2011) A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 26:775-783
10. Kaye J, Gage H, Kimber A et al (2006) Excess burden of constipation in Parkinson's disease: a pilot study. Mov Disord 21:1270-1273
11. Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5:235-245
12. Verbaan D, Marinus J, Visser M et al (2007) Patient-reported autonomic symptoms in Parkinson disease. Neurology 69:333-341
13. Makaroff L, Gunn A, Gervasoni C, Richy F (2011) Gastrointestinal disorders in Parkinson's disease: Prevalence and health outcomes in a US claims database. J Parkinsons Dis 21:1-10
14. Cersósimo MG, Benarroch EE (2008) Neural control of the gastrointestinal tract: implications for Parkinson disease. Mov Disord 23:1065-1075
15. Cooke HJ (1989) Role of the "little brain" in the gut in water and electrolyte homeostasis. FASEB 3:127-138
16. Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211
17. Del Tredici K, Rüb U, Vos RAI de et al (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413-426
18. Eadie MJ (1963) The pathology of certain medullary nuclei in parkinsonism. Brain 86:781-792
19. Braak H, Del Tredici K (2009) Neuroanatomy and pathology of sporadic Parkinson's disease. Adv Anat Embryol Cell Biol 201:1-119
20. Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010) Evidence in favor of Braak staging of Parkinson's disease. Mov Disord 25(Suppl 1):78-82
21. Wakabayashi K, Takahashi H, Ohama E et al (1993) Lewy bodies in the visceral autonomic nervous system in Parkinson's disease. Adv Neurol 60:609-612
22. Wakabayashi K, Takahashi H, Takeda S et al (1988) Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 76:217-221
23. Braak H, Del Tredici K (2008) Nervous system pathology in sporadic Parkinson's disease. Neurology 70:1916-1925
24. Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F et al (2007) Do a-synuclein aggregates in autonomic plexuses predate Lewy body disorders? Neurology 68:2012-2018
25. Beach TG, Adler CH, Sue L et al (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689-702
26. Pouclet H, Lebouvier T, Coron E et al (2011) A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease. Neurobiol Dis 45:305-309
27. Shannon KM, Deshavarzian A, Mutlu E et al (2011) Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord 27:709-715
28. Cersósimo MG, Tumilasci OR, Raina GB et al (2009) Hyposialorrhea as an early manifestation of Parkinson disease. Auton Neurosci 150:150-151
29. Qualman SJ, Haupt HM, Yang P, Hamilton SR (1984) Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's. Gastroenterology 87:848-856
30. Bushmann M, Dobmeyer SM, Leeker L, Perlmutter JS (1989) Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology 39:1309-1314
31. Evatt ML, Chaudhuri KR, Chou KL et al (2009) Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation - critique and recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's disease. Mov Disord 24:635-646
32. Leopold NA, Kagel MC (1997) Pharyngo-esophageal dysphagia in Parkinson's disease. Dysphagia 12:11-18
33. Chou KL, Evatt M, Hinson V, Kompoliti K (2007) Sialorrhea in Parkinson's disease: a review. Mov Disord 22:2306-2313
34. Bagheri H, Damase-Michel C, Lapeyre-Mestre M et al (1999) A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol 22:213-215
35. Tumilasci OR, Cersosimo MG, Belforte JE et al (2006) Quantitative study of salivary secretion in Parkinson's disease. Mov Disord 21:660-667
36. Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H (2010) Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Acta Neuropathol 119:703-713
37. Djaldetti R, Baron J, Ziv I, Melamed E (1996) Gastric Emptying in Parkinson's disease: Patients with and without response fluctuations. Neurology 46:1051-1054
38. Hardoff R, Sula M, Tamir A et al (2001) Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 16:1041-1047
39. Unger MM, Hattemer K, Moller JC et al (2010) Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's disease. Mov Disord 25:623-628
40. Unger MM, Möller JC, Mankel K et al (2011) Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the (13) C-octanoate breath test. Mov Disord 26:2569-2563
41. Unger MM, Möller JC, Mankel K et al (2011) Postprandial ghrelin response is reduced in patients with Parkinson's disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson's disease? J Neurol 258:982-990
42. Goetze O, Nikodem AB, Wiezcorek J et al (2006) Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol Motil 18:369-375
43. Eggert K, Schrader C, Hahn M et al (2008) Continuous jejunal levodopa infusion in patients with advanced parkinson disease: practical aspects and outcome of motor and non-motor complications. Clin Neuropharmacol 31:151-166
44. Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2:107-116
45. Lewitan A, Nathanson L, Slade WR (1951) Megacolon and dilatation of the small bowel in parkinsonism. Gastroenterology 17:367-374
46. Goetze O, Wieczorek J, Mueller T et al (2005) Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13 C-sodium octanoate breath test. Neurosci Lett 375:170-173
47. Jost WH (1999) Treatment of drooling in Parkinson's disease with botulinum toxin. Mov Disord 14:1057
48. Naumann M, So Y, Argoff CE et al (2008) Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review). Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70:1707-1714
49. Chinnapongse R, Gullo K, Nemeth P et al (2011) Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial. Mov Disord 27:219-226
50. Parkinson J (1817) An essay on the shaking palsy. Sherwood, Neely and Jones, London
51. Klaue R (1940) Parkinsonsche Krankheit (Paralysis agitans) und postencephalitischer Parkinsonismus. Arch Psychiatr 111:251-321
52. Schwab RS, England AC (1958) Parkinson's disease. J Chron Dis 8:488-509
53. Calne DB, Brennan J, Spiers ASD et al (1970) Hypotension caused by L-dopa. Br Med J 1:474-475
54. Caplan LH, Jacobson HG, Rubinstein BM, Rotman MZ (1965) Megacolon and volvulus in Parkinson's disease. Radiology 85:73-78
55. Eadie MJ, Tyrer JH (1965) Alimentary disorder in parkinsonism. Australas Ann Med 14:13-22
56. Kuroiwa Y, Shimada Y, Toyokura Y (1983) Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology 33:463-467
57. Turkka JT, Juujärvi KK, Lapinlampi TO, Myllylä VV (1986) Serum noradrenaline response to standing up in patients with Parkinson's disease. Eur Neurol 25:355-361
58. Edwards LL, Pfeiffer RF, Quigley EMM et al (1991) Gastrointestinal symptoms in Parkinson's disease. Mov Disord 6:151-156
59. Edwards L, Quigley EMM, Hofman R, Pfeiffer RF (1993) Gastrointestinal symptoms in Parkinson Disease: 18-month follow-up study. Mov Disord 8:83-86
60. Mesec A, Šega S, Kiauta T (1993) The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic responses. Clin Auton Res 3:339-344
61. Edwards LL, Quigley EMM, Harned RK et al (1994) Characterization of swallowing and defecation in Parkinson's disease. Am J Gastroenterol 89:15-25
62. Korczyn AD (1990) Autonomic nervous system disturbances in Parkinson's disease. Adv Neurol 53:463-468
63. Jost WH, Schimrigk K (1991) Constipation in Parkinson's disease. Klin Wochenschr 69:906-909
64. Wang SJ, Fuh JL, Shan DE et al (1993) Sympathetic skin response and R-R interval variation in Parkinson's disease. Mov Disord 8:151-157
65. Sakakibara R, Shinotoh H, Uchiyama T et al (2001) Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 92:76-85
66. Pallis CA (1971) Parkinsonism: Natural history and clinical features. Br Med J 3:683-690
67. Singer C, Weiner WJ, Sanchez-Ramos JR (1992) Autonomic dysfunction in men with Parkinson's disease. Eur Neurol 32:134-140
68. Abbott RD, Petrovitch H, White LR et al (2001) Frequency of bowel movements and the risk of Parkinson's disease. Neurology 57:456-462
69. Savica R, Cartin JM, Grossardt BR et al (2009) Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology 73:1752-1758
70. Jost WH (1997) Gastrointestinal motility problems in patients with Parkinson's disease: Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 10:249-258
71. Siegmund H (1935) Anatomisch nachgewiesene Folgen von Tonus- und Motilitätsstörungen des Verdauungskanals bei Enzephalitikern, die mit Atropin behandelt wurden. MMW 82:453-454
72. Hartog Jager WA den, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23:283-290
73. Ohama E, Ikuta F (1976) Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol 34:311-319
74. Forno LS (1986) The Lewy body in Parkinson's disease. Adv Neurol 45:35-43
75. Kupsky WJ, Grimes MM, Sweeting J et al (1987) Parkinson's disease and megacolon: Concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37:1253-1255
76. Oyanagi K, Wakabayashi K, Ohama E et al (1990) Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson's disease. Acta Neuropathol 80:558-559
77. Mitolo-Chieppa D, Mansi G, Rinaldi R et al (1998) Cholinergic stimulation and nonadrenergic, noncholinergic relaxation of human colonic circular muscle in idiopathic chronic constipation. Dig Dis Sci 43:2719-2726
78. Wakabayashi K, Takahashi H, Ohama E, Ikuta F (1990) Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol 79:581-583
79. Singaram C, Ashraf W, Gaumintz EA et al (1995) Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 346:861-864
80. Anlauf M, Schäfer MK, Eiden L, Weihe E (2003) Chemical coding of the human gastrointestinal nervous system. Cholingergic, VIPergic, and catecholaminergic phenotypes. J Comp Neurol 459:90-111
81. Mathers SE, Kempster PA, Law PJ et al (1989) Anal sphincter dysfunction in Parkinson's disease. Arch Neurol 46:1061-1064
82. Jost WH, Schrank B (1998) Defecatory disorders in de novo Parkinsonians - colonic transit and electromyogram of the external anal sphincter. Wien Klin Wochenschr 110:535-537
83. Mathers SE, Kempster PA, Swash M, Lees AJ (1988) Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon? J Neurol Neurosurg Psychiatry 51:1503-1507
84. Ashraf W, Pfeiffer RF, Quigley EMM (1994) Anorectal manometry in the assessment of anorectal function in Parkinson's disease: a comparison with chronic idiopathic constipation. Mov Disord 9:655-663
85. Jost WH, Schrank B, Herold A, Leiß O (1999) Functional outlet obstruction: Anismus, spastic pelvic floor syndrome, and dyscoordination of the voluntary sphincter muscles. Scand J Gastroenterol 34:449-453
86. Jost WH, Schimrigk K (1992) Bestimmung der Kolontransitzeit beim Parkinson-Syndrom. Akt Neurol 19:52-53
87. Bassotti G, Maggio D, Battaglia E et al (2000) Manometric investigation of anorectal function in early and late stage Parkinson's disease. J Neurol Neurosurg Psychiatry 68:768-770
88. Eardley I, Quinn NP, Fowler CJ et al (1989) The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. Br J Urol 64:360-362
89. Jost WH, Schimrigk K (1996) Elektromyogramm des M. sphincter ani externus beim idiopathischen Parkinson Syndrom. Akt Neurol 23:167-170
90. Thomaides T, Karapanayiotides T, Zoukos Y et al (2005) Gastric emptying after semi-solid food in multiple system atrophy and Parkinson disease. J Neurol 252:1055-1059
91. Astarloa R, Mena MA, Sanchez V et al (1992) Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson's disease. Clin Neuropharmacol 15:375-380
92. Ashraf W, Pfeiffer RF, Park F et al (1997) Constipation in Parkinson's disease: objective assessment and response to psyllium. Mov Disord 12:946-951
93. Zesiewicz TA, Sullivan KL, Arnulf I et al (2010) Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74:924-931
94. Paulseth JE, Jensen JJJ, Klawans HL (1984) Domperidone therapy in patients with Parkinson's disease with levodopa-carbidopa-related gastrointestinal complaints. Ann Neurol 16:127-128
95. Parkes JD (1986) Domperidone and Parkinson's disease. Clin Neuropharmacol 9:517-532
96. Soykan I, Sarosiek I, Shifflett J et al (1997) Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease. Mov Disord 12:952-957
97. (o A) (2002) Task force MDS. Management of Parkinson's disease: an evidence-based review. Drugs to treat autonomic dysfunction in Parkinson's disease. Mov Disord 17(Suppl 4):103-111
98. Edwards LL, Quigley EM, Harned RK et al (1993) Defecatory function in Parkinson's disease: response to apomorphine. Ann Neurol 33:490-493
99. Eichhorn TE, Oertel WH (2001) Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy. Mov Disord 16:1176-1177
100. Zangaglia R, Martignoni E, Glorioso M et al (2007) Magrocol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study. Mov Disord 22:1239-1244
101. Albanese A, Maria G, Bentivoglio AR (1997) Severe constipation in Parkinson's disease relieved by botulinum toxin. Mov Disord 12:764-766
102. Albanese A, Brisinda G, Bentivoglio AR, Maria G (2003) Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. Am J Gastroenterol 98:1439-1440
103. Jost WH, Jung G, Schimrigk K (1994) Colonic transit in non-idiopathic Parkinson's syndrome. Eur Neurol 34:329-331
104. Harari D, Gurwitz JH, Avorn J et al (1996) Bowel habit in relation to age and gender: findings from the National Health Interview Survey and Clinical Implications. Arch Intern Med 156:315-320
105. Stocchi F, Badiali D, Vacca L et al (2000) Anorectal function in multiple system atrophy and Parkinson's disease. Mov Disord 15:71-76
106. Quigley EM (1996) Gastrointestinal dysfunction in Parkinson's disease. Semin Neurol 16:245-250
107. Forsyth CB, Shannon KM, Kordower JH et al (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One 6:e28032
108. Kuroiwa Y, Wada T, Tohgi H (1987) Measurement of blood pressure and heart-rate variation while resting supine and standing for the evaluation of autonomic dysfunction. J Neurol 235:65-68
109. Porter RW, Bors E (1971) Neurogenic bladder in parkinsonism: effect of thalamotomy. J Neurosurg 34:27-32
110. Braak H, Rüb U, Gai WP, Del Tredici K (2033) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517-536
111. McBride PA, Schulz-Schaeffer WJ, Donaldson M et al (2011) Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves. J Virol 75:9320-9327
112. Phillips RJ, Walter GC, Wilder SL et al (2008) Alpha-synuclein immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease? Neuroscience 153:733-750
113. Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317-325
114. Pan-Montojo F, Anichtchik O, Dening Y et al (2010) Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5:e8762
115. Dunning CJ, Revews JF, Steiner JA, Brundin P (2011) Can Parkinson's disease pathology be propagated from one neuron to another? Prog Neurobiol 97:205-219